Dr. Alex Tatem
Coverage of Dr. Alex Tatem in the Nexus archive.
- FDA to review 7 popular peptides touted for weight loss, healing and longevity
The FDA is reviewing seven unapproved peptides for potential inclusion in compounded prescription drugs, with meetings scheduled for July 23-24. These peptides, popular for weight loss, wound healing, and other health claims, are widely available through clinics and online sellers despite lacking FDA approval. HHS Secretary Robert F. Kennedy Jr. supports expanding access, while FDA reviewers express concerns about safety and efficacy.
- ‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
The peptide market is experiencing rapid growth as GLP-1 weight-loss medications gain popularity, with largely unregulated peptides being sold through compounding pharmacies and unverified vendors. The FDA is evaluating whether to loosen regulations on several peptides, while compounding pharmacies have expanded to meet demand and offer dosing flexibility that commercial products cannot provide.